GLP-1 (glucagon-like peptide-1) is a hormone-based therapeutic class used to improve insulin secretion and regulate blood sugar levels
The methodological quality of the studies was analyzed through the Jadad Scale or Oxford Quality Scoring System, a critical reading tool with 5 questions associated with clinical trial analysis, which classifies the study as of low quality if its score is below 3, and considers rigorous a randomized clinical trial with a score of 510
The table calls for baseline TSH before GLP-1 initiation, then every 6 to 8 weeks during dose escalation, then quarterly once levels are stable
The study results suggested that polyphenol consumption escalated with age, with a more pronounced increase observed in male subjects
doi: 10.4251/wjgo.v11.i9.686 146 SongLGuoXZhaoFWangWZhaoZJinLet al
Gysin R, Kraftsik R, Sandell J, Bovet P, Chappuis C, et al